BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2418497)

  • 21. Immunochemical measurement of serum prostatic acid phosphatase (PAP). Clinical evaluation of radioimmunoassay and counter immunoelectrophoresis.
    Gupta MK; Rajaraman S; Gupta SK; Hewitt CB; Deodhar SD
    Am J Clin Pathol; 1981 Oct; 76(4):430-6. PubMed ID: 6170220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current experience with radioimmunoassay techniques for prostatic acid phosphatase.
    Cooper JF; Finkle WD
    Prostate; 1980; 1(4):441-50. PubMed ID: 7279809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic efficiency of biological markers in blood serum on prostate cancer: a comparison of four different markers and 12 different methods.
    Strømme JH; Haffner F; Johannessen NB; Talseth T; Frederichsen P; Theodorsen L
    Scand J Clin Lab Invest; 1986 Sep; 46(5):443-50. PubMed ID: 2428093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase].
    Gaca A; Panitz N
    Helv Chir Acta; 1981 Aug; 48(3-4):465-6. PubMed ID: 7287485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of serum prostatic acid phosphatase measurements for detection (screening), diagnosis, and therapeutic monitoring of prostatic carcinoma; assessment of monoclonal and polyclonal enzymes and radioimmunoassays.
    Kaplan LA; Chen IW; Sperling M; Bracken B; Stein EA
    Am J Clin Pathol; 1985 Sep; 84(3):334-9. PubMed ID: 4036863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
    Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma.
    Debruyne FM; van Munster PJ; van Groeninghen JC; Kirkels WJ
    Urol Res; 1984; 12(5):233-7. PubMed ID: 6083652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human prostatic acid phosphatases: III. Counterimmunoelectrophoresis for rapid identification.
    McDonald I; Rose NR; Pontes EJ; Choe BK
    Arch Androl; 1978 May; 1(3):235-9. PubMed ID: 83816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical comparison of immunological assays for determining prostatic acid phosphatase.
    Romas NA; Shaw LM; Hsu KC; Ng PY; Pitts M; Tomashefsky P; Tannenbaum M
    Ann N Y Acad Sci; 1982; 390():104-9. PubMed ID: 6178342
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunoenzyme assay for prostate-specific acid phosphatase in prostatic cancer].
    Bauer HW
    Med Welt; 1982 Nov; 33(46):1616-21. PubMed ID: 6185820
    [No Abstract]   [Full Text] [Related]  

  • 31. [New prospective diagnostic serum markers in prostatic cancer].
    Mirone V; De Bellis G; Prezioso D; Sanseverino R; Iannucci F; Padulano P
    Minerva Med; 1986 Mar; 77(13):503-4. PubMed ID: 2422605
    [No Abstract]   [Full Text] [Related]  

  • 32. The value of acid phosphatase measurements in predicting extraprostatic cancer growth before radical prostatectomy.
    Salo JO; Rannikko S
    Br J Urol; 1988 Nov; 62(5):439-42. PubMed ID: 3208023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple marker evaluation in prostatic cancer with prostatic acid phosphatase, gamma-seminoprotein and prostate-specific antigen.
    Fuse H; Umeda K; Mizuno I; Katayama T
    Int Urol Nephrol; 1991; 23(5):455-63. PubMed ID: 1718922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioimmunoassay of serum prostatic acid phosphatase in prostatic cancer.
    Br Med J; 1978 Sep; 2(6139):719-20. PubMed ID: 698693
    [No Abstract]   [Full Text] [Related]  

  • 35. Secretion into and elimination from blood circulation of prostate specific acid phosphatase, measured by radioimmunoassay.
    Vihko P; Schroeder FH; Lukkarinen O; Vihko R
    J Urol; 1982 Jul; 128(1):202-4. PubMed ID: 6180187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological and colorimetric determination of prostatic acid phosphatase--technical and clinical reappraisal in symptomatic patients.
    Gibb I; Wilson LA; Powell PH; Tarbit I; Pratt D; Hall RR
    Clin Chem; 1986 Sep; 32(9):1760-6. PubMed ID: 2427260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acid phosphatase (ACP)].
    Igawa M; Kishi H; Ishibe T
    Nihon Rinsho; 1995 May; 53(5):1203-8. PubMed ID: 7602779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of lactic dehydrogenase isoenzymes in prostatic tissue with serum acid phosphatase, digital examination and histological diagnosis.
    Clark SS; Srinivasan V
    J Urol; 1973 Mar; 109(3):444-5. PubMed ID: 4120831
    [No Abstract]   [Full Text] [Related]  

  • 39. [A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma].
    Bentvelsen FM; Bogdanowicz JF; Oosterom R; Schröder FH
    Ned Tijdschr Geneeskd; 1990 Aug; 134(33):1596-600. PubMed ID: 1697651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers.
    Seamonds B; Yang N; Anderson K; Whitaker B; Shaw LM; Bollinger JR
    Urology; 1986 Dec; 28(6):472-9. PubMed ID: 2431533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.